A5021770094- Prostate Cancer Diagnosis and Treatment
- Urinary Bladder and Prostate Research
- Urologic and reproductive health conditions
- Urological Disorders and Treatments
- Uterine Myomas and Treatments
- Hepatocellular Carcinoma Treatment and Prognosis
- Hormonal and reproductive studies
- Liver Disease and Transplantation
- Prostate Cancer Treatment and Research
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Maternal and fetal healthcare
- Organ Transplantation Techniques and Outcomes
- Endometriosis Research and Treatment
- Vascular anomalies and interventions
- Abdominal vascular conditions and treatments
- Orthopedic Surgery and Rehabilitation
- Sexual function and dysfunction studies
- Liver Disease Diagnosis and Treatment
- Pelvic and Acetabular Injuries
- Venous Thromboembolism Diagnosis and Management
- Pelvic floor disorders treatments
- Radiomics and Machine Learning in Medical Imaging
- Esophageal and GI Pathology
- Cholangiocarcinoma and Gallbladder Cancer Studies
Hospital Curry Cabral
2017-2025
Centro Hospitalar de Lisboa Central
2015-2024
Universidade Nova de Lisboa
2015-2024
Istituto di Istruzione Superiore I.T.C. Di Vittorio
2018
Altice Portugal (Portugal)
2018
Hospital de São José
2013-2017
National Statistical Institute of Portugal
2016-2017
Hospital of St. Francis Xavier
2017
Society of Interventional Radiology
2012-2013
American Association of Neurological Surgeons
2013
To evaluate the safety, morbidity, and short- intermediate-term results of prostatic arterial embolization (PAE) for benign hyperplasia (BPH) after failure medical treatment.This prospective study was approved by institutional review board, informed consent obtained from all participants. Men older than 50 years with a diagnosis BPH moderate-to-severe lower urinary tract symptoms that were refractory to treatment 6 months eligible. PAE nonspherical 80-180-μm (mean, 100-μm) 180-300-μm 200-μm)...
Purpose To assess predictors of outcome after prostate artery embolization (PAE) for benign prostatic hyperplasia with spherical particle polyvinyl alcohol (sPVA) and compare outcomes the use nonspherical (nsPVA). Materials Methods This was a single-center retrospective institutional review board-approved study conducted from 2009 to 2015 in patients undergoing PAE sPVA (n = 186; mean age ± standard deviation, 65.5 years 7.7) nsPVA 300; age, 65.3 7.6). The two cohorts were compared analyzed...
Background In patients with liver cancer, portal vein embolization (PVE) is recommended to promote growth before major hepatectomies. However, the optimal strategy has not been established. Purpose To compare regeneration as seen at CT in participants hepatectomies, N-butyl-cyanoacrylate (NBCA) plus iodized oil versus standard polyvinyl alcohol (PVA) particles coils, for PVE. Materials and Methods this single-center, prospective, randomized controlled trial (Best Future Liver Remnant, or...
Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists and provides best practices for performing liver regeneration therapies prior to major hepatectomies, including portal vein embolization, double embolization venous deprivation. It has been developed by an expert writing group under the guidance Committee. encompasses all clinical technical details required perform therapies, revising indications, contra-indications, outcome measures assessed,...